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The eukaryotic initiation factor 2-associated 67-kDa polypeptide
(p67) plays a critical role in regulation of protein synthesis
initiation in animal cells
(translational regulation/peptide chain initiation/protein phosphorylation)
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SUSANNE MEZA-KEUTHEN, AND NABA K. GUPTAt
Department of Chemistry, University of Nebraska, Lincoln, NE 68588-0304
Communicated by Myron K. Brakke, October 18, 1991 (received for review August 1, 1991)
ABSTRACT The eukaryotic initiation factor 2 (eIF-2)-
associated 67-kDa polypeptide (p67) isolated from reticulocyte
lysate protects the eIF-2 a subunit from eIF-2 kinase-catalyzed
phosphorylation and promotes protein synthesis in the pres-
ence of active eIF-2 kinases. We have now studied the roles of
p67 and eIF-2 kinases in regulation of protein synthesis using
several animal cell lysates and an animal cell line (KRC-7) in
culture under various growth conditions. The results are as
follows. (s) Both p67 and eIF-2 kinase(s) are present in active
forms in all animal cells under normal growth conditions and
p67 protects the eIF-2 a subunit from eIF-2 kinase-catalyzed
phosphorylation, thus promoting protein synthesis in the pres-
ence of active eIF-2 kinases. (u) In heme-deficient reticulocyte
lysates and in serum-starved KRC-7 cells in culture, p67 is
deglycosylated and subsequently degraded. This leads to eIF-2
kinase-catalyzed eIF-2 a-subunit phosphorylation and thus to
protein synthesis inhibition. (iii) Addition of a mitogen (name-
ly, phorbol 12-myristate 13-acetate) to serum-starved KRC-7
cells in culture induces an increase of p67 and thus increases
protein synthesis. These results suggest the following conclu-
sions. (a) Protein synthesis inhibition in a heme-deficient retic-
ulocyte lysate is not due to the activation of an eIF-2 kinase
(heme-regulated inhibitor), as is generally believed, but is due
to degradation of p67. The heme-regulated inhibitor is present
in an active form and possibly in equal amounts in both
heme-deficient and heme-supplemented reticulocyte lysates but
cannot phosphorylate eIF-2 a subunit because of the presence
of p'7. (ii) p67 is essential for protein synthesis as it protects the
eIF-2 a subunit from eIF-2 kinase-catalyzed phosphorylation
and promotes protein synthesis in the presence of one or more
active eIF-2 kinases present in all animal cells. (iii) p67 is both
degradable and inducible. Only the p67 level correlates directly
with the protein synthesis activity of the cell, indicating that p67
is a critical factor in protein synthesis regulation in animal cells.
A widely used protein synthesis regulatory mechanism in
animal cells involves phosphorylation of the a subunit of a
key peptide chain initiation factor, eukaryotic initiation fac-
tor 2 (eIF-2), by one or more eIF-2 kinases, which inhibits
protein synthesis. In several cases studied, these inhibitors
appear to remain in an inactive form and are activated under
certain physiological conditions. Numerous reports indicate
that in reticulocyte lysates one inhibitor, heme-regulated
inhibitor (HRI), is activated in the absence of hemin and
another inhibitor, double-stranded-RNA-activated inhibitor
(dsI), is activated in the presence of double-stranded RNA
(for reviews, see refs. 1 and 2). In both cases the activated
inhibitor specifically phosphorylates the eIF-2 a subunit and
thus inactivates eIF-2 activity and inhibits protein synthesis.
As noted earlier, this regulatory mechanism involving eIF-2
a-subunit phosphorylation is widely used in animal cells to
regulate protein synthesis under various physiological con-
ditions, which include nutritional deprivation (3, 4), heat
shock (4-6), and viral infection (7-14).
We have observed that a 67-kDa polypeptide, p67, which
remains associated with reticulocyte eIF-2 through several
steps of purification, protects the eIF-2 a subunit from eIF-2
kinase-catalyzed phosphorylation, thus promoting protein
synthesis in the presence of activated eIF-2 kinases (15). p67
is a glycoprotein and contains multiple 0-linked GlcNAc
residues (16). There are indications that the glycosyl residues
on p67 may be necessary to protect the eIF-2 a subunit from
eIF-2 kinase-catalyzed phosphorylation. Based on our re-
sults, we postulated that protein synthesis in animal cells may
be regulated by eIF-2 kinases and by the availability of p67.
eIF-2 kinases phosphorylate the eIF-2 a subunit and thus
inhibit protein synthesis, and the increased availability of p67
renders the eIF-2 a subunit resistant to eIF-2 kinase-
catalyzed phosphorylation, which promotes protein synthe-
sis in the presence of eIF-2 kinases. Two reports from our
laboratory are in agreement with this hypothesis (17, 18).
In the present study, we have examined the roles of p67 and
the eIF-2 kinases in regulation of protein synthesis using
several animal cell lysates and also an animal cell line
(KRC-7) in culture under various growth conditions. We
provide evidence that p67 and one or more eIF-2 kinases are
present in active forms in all animal cells under normal
growth conditions. However, eIF-2 kinases cannot phos-
phorylate the eIF-2 a subunit because of the presence of p67.
Under certain physiological conditions, such as during heme
deficiency in reticulocyte lysates and also in serum-starved
animal cells in culture, p67 is degraded and thus eIF-2
kinase(s) are able to phosphorylate the eIF-2 a subunit and
inhibit protein synthesis. p67 is both inducible and degrad-
able. Also, p67 levels in the cells correlate directly with the
protein synthesis activity of the cells, suggesting that p67
plays a critical role in regulation of protein synthesis.
MATERIALS AND METHODS
Most of the materials used in this study were as described
(15-17). The cloned cell line KRC-7 derived from Reuber H35
rat hepatoma cells was kindly provided by John Koontz
(University of Tennessee, Knoxville). A sample of dsI pre-
pared according to Kudlicki et al. (19) was generously
Abbreviations: eIF-2, eukaryotic initiation factor 2; URI, heme-
regulated inhibitor; dsI, double-stranded-RNA-activated inhibitor;
WGA, wheat germ agglutinin; PMA, phorbol 12-myristate 13-
acetate.
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donated by Gisela Kramer (Clayton Foundation, Biochem-
istry Institute, Austin, TX). A 10,000 x g cell supernatant
from rat liver and from rat brain was prepared as described
by Pain et al. (20).
Preparation of Antibodies. Polyclonal antibodies against
eIF-2 a or /3 subunits or against p67 were prepared using a
modification of the procedure described (15, 16). The isolated
polypeptides were injected into mice. When the antibody titer
in the serum was >1:1000, the mouse was injected with
TG-180 sarcoma cells (obtained from American Type Culture
Collection) for generation of ascites fluid. Antibodies from
the ascites fluid were purified on DEAE-Affi-Gel Blue,
according to the procedure supplied by the manufacturer
(Bio-Rad), and were characterized by NaDodSO4/PAGE
followed by immunoblot analysis. dsI was purified from
interferon-p-induced HeLa cells by the procedure of Ray et
al. (21) and was injected into rabbit. Immune serum from the
rabbit was purified on DEAE-Affi-Gel Blue and character-
ized as above. The monoclonal antibodies against p67 were
prepared as described (16). As reported these monoclonal
antibodies specifically recognize the GlcNAc moieties on p67
(16). All the antibodies were monospecific and reacted only
with their corresponding antigens.
Cell Culture. KRC-7 cells were grown in Dulbecco's mod-
ified Eagle's medium (DMEM), containing 5% (vol/vol) fetal
calf serum and 5% (vol/vol) calf serum. The experimental
procedures were essentially similar to those described by
Trevillyan et al. (22). Serum-starved cells were prepared by
washing cell monolayers with Hanks' balanced salt solution
followed by culturing in serum-free DMEM for an additional
3 days. The serum-starved cells were stimulated by addition
of 1.5 1LM phorbol 12-myristate 13-acetate (PMA) (Sigma).
For analysis, 6 x 105 cells were seeded onto 100-mm tissue
culture dishes containing 10 ml of medium.
Cell Lysate Preparation. Cells were harvested, washed
twice with phosphate-buffered saline (PBS, GIBCO), and
lysed with lysis buffer [20 mM Hepes, pH 7.5/10 mM
KCl/1.5 mM Mg(OAc)2/2 mM dithiothreitol]. Cell lysates
were centrifuged at 10,000 rpm in a Beckman Microfuge B
centrifuge for 10 min. Supernatants were stored at -70°C.
The concentration of proteins in the lysate was measured by
Bio-Rad protein assay kit using a bovine serum albumin
standard.
RESULTS
Assays for eIF-2 Kinase and p67 Activities. To assay both
eIF-2 kinase(s) and p67 activities in a mixture, we developed
an experimental procedure that measures eIF-2 a-subunit
phosphorylation in the mixture before and after inhibition of
67 6p activity by preincubation with either p67 antibodies or
wheat germ agglutinin (WGA). As reported (16), WGA binds
to the glycosyl residues on p67 and interferes with the p67
activity to protect the eIF-2 a subunit from eIF-2 kinase-
catalyzed phosphorylation.
The results of this assay are shown in Fig. 1. As before, HRI
efficiently phosphorylated the three-subunit eIF-2 (lane 1) and
addition of p67 protected the eIF-2 a subunit from phosphor-
ylation (lane 2). However, the ability of p67 to protect the eIF-2
a subunit was almost completely inhibited by preincubation of
the mixture of eIF-2 and p67 with either p67 antibodies (lane 3)
or WGA (lane 6). Under similar conditions, preincubation of
the mixture of eIF-2 and p67 with either eIF-2 a-subunit or
p-subunit antibodies had no significant effect (lanes 4 and 5).
None of the antibodies (p67 or eIF-2 a or P subunits), when
added alone in the absence of p67, inhibited HRI-catalyzed
phosphorylation of the eIF-2 a subunit (data not shown). We
also analyzed various antibody-treated incubation mixtures
for possible degradation of p67 by a standard immunoblot
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FIG. 1. Assay for eIF-2 kinases and p67 activities. Reaction
conditions for HRI-catalyzed phosphorylation of eIF-2 a subunit
were as described (15). A 25-,ul reaction mixture contained 20 mM
Tris-HCl (pH 7.8), 100 mM KCI, 10 ,g of bovine serum albumin, 2
mM dithiothreitol, 3 ug ofeIF-2 (fraction V), 1.6 ,g of p67, and where
indicated 10 ,g of polyclonal antibodies against p67 or against eIF-2
a or ,B subunits or 10 ,ug of WGA. Reaction mixtures were incubated
on ice for 1 hr, then 0.02 ug of HRI and 10 ,uCi [y-32P]ATP were
added, and the mixtures were further incubated at 37°C for 10 min.
The radioactively labeled eIF-2 a subunit was then analyzed by
NaDodSO4/PAGE followed by autoradiography. Lanes: 1, eIF-2
alone; 2, eIF-2 plus p67; 3, eIF-2, p67, plus p67 antibodies; 4, eIF-2,
p67, plus eIF-2 a-subunit antibodies; 5, eIF-2, p67, plus eIF-2 ,3-sub-
unit antibodies; 6, eIF-2, p67, plus WGA.
procedure. p67 remained undegraded during incubation (data
not shown).
We carried out similar experiments using purified dsI in
place of HRI and the results were similar. p67 inhibited
dsl-catalyzed phosphorylation of eIF-2 a subunits. Also p67
antibodies and WGA inhibited this p67 activity, but eIF-2 a-
and p-subunit antibodies had no effect.
Studies Using Animal Cell Lysates. We used the above assay
to study eIF-2 kinase(s) and p67 activities in four cell lysates;
heme-deficient rabbit reticulocyte lysates, heme-supple-
mented rabbit reticulocyte lysates, and also cell lysates pre-
pared from rat liver and rat brain (Fig. 2). In the absence of p67
antibodies, significant eIF-2 a-subunit phosphorylation was
observed only with heme-deficient reticulocyte lysate. In
contrast, the heme-supplemented reticulocyte lysate and also
the lysates from liver and brain showed very little or no
phosphorylation. However, when the cell lysates were prein-
cubated with p67 antibodies significant phosphorylation of the
eIF-2 a subunit was observed with all of the cell lysates. The
extent of phosphorylation, with both heme-deficient and
heme-supplemented reticulocyte lysates, was comparable.
However, it should be noted that, although significant changes
in the phosphorylation pattern in all of the cell lysates con-
NU~~~~s.-... ..:
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FIG. 2. Analysis of eIF-2 kinases and p67 activities in various cell
lysates. Heme-deficient and heme-supplemented reticulocyte lysates
and also cell lysates from rat brain and rat liver were used. Heme-
deficient and heme-supplemented reticulocyte lysates prepared as
described (15) were preincubated at 37°C for 10 min before use.
Approximately 20 /J of reticulocyte lysate or 120 ,g of protein in brain
or liver extract was used. eIF-2 a-subunit phosphorylation by endog-
enous eIF-2 kinase(s) in the presence or absence of p67 antibodies was
carried out as described in Fig. 1 and phosphorylated proteins were
analyzed by NaDodSO4/PAGE and autoradiography. Lanes: 1, heme-
deficient reticulocyte lysate; 2, heme-deficient reticulocyte lysate-
preincubated with p67 antibodies; 3, heme-supplemented reticulocyte
lysate; 4, heme-supplemented reticulocyte lysate preincubated with p67
antibodies; 5, lysate from rat brain; 6, lysate from rat brain preincubated
with p67 antibodies; 7, lysate from rat liver; 8, lysate from rat liver
preincubated with p67 antibodies.
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taining p67 antibodies was observed with the eIF-2 a subunit,
one polypeptide of =200 kDa or more polypeptides present in
reticulocyte lysates and in rat brain and rat liver lysates
showed a similar change in phosphorylation pattern. The
significance of this observation will be discussed later.
These results, however, show that both eIF-2 kinase(s) and
p67 are present in active forms in all of the cell lysates and p67
inhibits eIF-2 a-subunit phosphorylation by active eIF-2 ki-
nases. Removal of p67 by p67 antibodies facilitated eIF-2
kinase-catalyzed phosphoiylation of the eIF-2 a subunit.
The results presented in Fig. 3 show that p67 is indeed
present in heme-supplemented reticulocyte lysate; and this
polypeptide is partially deglycosylated in heme-deficient re-
ticulocyte lysate. For these experiments the lysates were
preincubated with p67 monoclonal (Fig. 3A) or polyclonal (Fig.
3B) antibodies and the antigen-antibody complexes were
precipitated with protein A-agarose (23). The precipitates
were then assayed on an immunoblot using p67 polyclonal
antibodies. p67 is present in heme-supplemented reticulocyte
lysate (Fig. 3 A and B, lanes 2) and also in heme-deficient
reticulocyte lysate (Fig. 3 A and B, lanes 1). However, the
level of this polypeptide in heme-deficient reticulocyte lysate
was significantly lower. In experiments described in Fig. 3A,
p67 present in the lysates was immunoprecipitated using p67
monoclonal antibodies, which reacted only with glycosylated
p67. The p67 level in heme-deficient lysate (lane 1) was <20%
of that present in heme-supplemented lysate (lane 2), indicat-
ing extensive deglycosylation of p67 in heme-deficient lysate.
These results thus provide evidence that p67 is present in
both heme-supplemented and heme-deficient reticulocyte
lysates. In heme-deficient Iysate, p67 is partially deglycosy-
lated. This allows eIF-2 kinases to phosphorylate eIF-2 and
thus inhibit protein synthesis. Using a similar immunoblot
experiment, we also observed that p67 is present in glycosy-
A
2
67 kDA- - -
B
2
67kDA- ._, a__
lated form in both rat liver and rat brain extracts (data not
shown).
Studies Using a Tumor Hepatoma Cell Line (KRC-7). We
used a tumor hepatoma cell line (KRC-7) and analyzed the
roles of p67 and eIF-2 kinase(s) in regulating protein synthesis
under various growth conditions. We grew the cells to
confluency, then added serum-depleted medium for 3-4
days, and stimulated the serum-starved cells with a mitogen,
PMA. We measured the protein synthesis rate, the levels of
various polypeptides, and also activation states of eIF-2
kinase(s) at various times during confluency, after serum
starvation, and after PMA addition. Protein synthesis rate
was measured by incorporation of [35S]methionine into cel-
lular proteins as described (17). The protein synthesis rate
was maximum in confluent cells and was reduced to 30% of
the maximum level after 100 hr of serum starvation. Upon
PMA addition the serum-starved cells regained 70% of the
original protein synthesis activity of the confluent cells within
4 hr.
Levels of Various Polypeptides. Immunoblot analysis was
used to measure levels of various polypeptides (p67, dsl, and
eIF-2 83 and a subunits) at various times, after serum star-
vation and after PMA addition (Fig. 4). p67 levels were
measured using both monoclonal and polyclonal antibodies.
dsI and eIF-2,8- and a-subunit levels were measured using
polyclonal antibodies.
As shown in Fig. 4, levels of eIF-2 , and a subunits and,
more importantly, the level of dsI remained essentially un-
changed in confluent (-72 hr), serum-starved, and PMA-
stimulated cells. On the other hand, p67 levels changed
dramatically; p67 was prominent in confluent cells, disap-
peared rapidly after serum starvation, and became prominent
after PMA addition. A significant observation is that p67 level
decreased faster after serum depletion and appeared more
slowly after PMA addition when measured using monoclonal
antibodies than when measured using polyclonal antibodies.
These results, in agreement with our observation with heme-
deficient reticulocyte lysates (Fig. 3), suggest that the first
step after serum depletion may be deglycosylation of p67 and
that deglycosylated p67 is subsequently degraded.
eIF-2 Kinase Activity. The results presented in Fig. 4 show
that the dsI polypeptide level remains essentially unchanged
under various growth conditions. However, the eIF-2 ki-
nases, such as HRI and dsI, may remain in either active or
inactive forms. We have, therefore, analyzed eIF-2 kinase
a-
_ft* ow so MO
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FIG. 3. Analysis of p67 in heme-deficient and heme-supplemented
reticulocyte lysates. Reticulocyte lysates (40 1l) without .or with
hemin (25 ,u) were incubated for 10 min at 37°C. (A) The lysates were
mixed with 25 ,g of p67 monoclonal antibodies. (B) The lysates were
mixed with 25 ,g of p67 polyclonal antibodies. The reaction mixtures
were incubated at 4°C overnight and antigen-antibody complexes
were precipitated by adding 30 ,ul of protein A-agarose (GIBCO)
followed by gentle tapping of the suspension for 1 hr at room
temperature. The precipitates were then washed three times with 1 x
PBS containing 0.05% Nonidet P-40. The polypeptides in the pre-
cipitates were then separated by NaDodSO4/PAGE on 15% gels and
subsequently transferred electrophoretically to a nitrocellulose
sheet. Lanes were excised from the blot and incubated with p67
antibodies as described by Bio-Rad (Bio-Rad immunoblot assay kit).
The antigen-antibody complexes were then detected using goat
anti-mouse IgG conjugated to horseradish peroxidase (Bio-Rad). (A)
Lanes: 1, heme-deficient lysate; 2, heme-supplemented lysate. (B)
Lanes: 1, heme-deficient lysate; 2, heme-supplemented lysate. The
lower molecular mass bands represent the IgG heavy chain.
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FIG. 4. Immunoblot analysis of p67, dsl, eIF-2 ,3 subunit (p54), and
eIF-2 a subunit (p38) in tumor hepatoma cells (KRC-7) that are
confluent, quiescent, or PMA-induced. Cells grown to confluency
(lane -72 hr) were transferred to serum-depleted medium and after 72
hr (lane 0 hr) were treated with PMA. Approximately 120 ,ug of protein
in cell lysates was analyzed on an immunoblot using p67 monoclonal
antibodies (row a), p67 polyclonal antibodies (row b), dsl polyclonal
antibodies (row c), eIF-2 /-subunit polyclonal antibodies (row d), and
eIF-2 a-subunit polyclonal antibodies (row e). The immunoblot pro-
cedure for detection of p67 and eIF-2 a and eIF-2 / subunits was the
same as described in Fig. 3. The immunoblot procedure for detection
of dsl was the same except that goat anti-rabbit IgG conjugated to
horseradish peroxidase was used to detect dsl rabbit antibodies.
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activities by analyzing eIF-2 a-subunit phosphorylation of
endogenous eIF-2 using cell extracts at various times after
the assay as described in Fig. 1. eIF-2 a-subunit phosphor-
ylation was low with extracts from confluent and PMA-
induced cells but was significantly increased when a similar
extract from quiescent cell was used (Fig. SA). However, as
described in Fig. 1, when the same cell extracts were first
preincubated with p67 polyclonal antibodies to remove en-
dogenous p67 (Fig.SB) or with WGA to inhibit the eIF-2-p67
interaction (Fig. 5C), the extent of eIF-2 a-subunit phos-
phorylation using all the cell extracts was significantly in-
creased to approximately the same level.
DISCUSSION
Data presented in this report provide evidence that all animal
cells contain one or more eIF-2 kinases in the active form and
the activities ofthese eIF-2 kinases may or may not be evident,
depending on the variable presence of p67. p67 protects the
eIF-2 a subunit from eIF-2 kinase-catalyzed phosphorylation
and thuspromotes protein synthesis in the presence of active
eIF-2 kinase(s).
In separate experiments we observed that p67 specifically
protects the eIF-2 a subunit from both HRI- and dsI-
catalyzed phosphorylation but does not inhibit dsI-catalyzed
phosphorylation of histones or casein kinase catalyzed phos-
phorylation of the eIF-28 subunit (data not shown). How-
ever, the results presented in Fig. 2 indicate that p67 also
inhibits phosphorylation of one or more additional proteins
(30 and 110 kDa) present in reticulocyte lysates and also in rat
brain and rat liver lysates. It may be that under in vitro
conditions, the glycosyl residues ofp67 may bind to these
additional proteins and thus inhibit their phosphorylation. On
the other hand, the possibility that p67 may inhibit phosphor-
ylation of a select group of closely related proteins cannot be
ruled out. However, abundant evidence reported previously
and also presented in this paper suggests that a major function
ofp67 is to protect the eIF-2 a subunit from eIF-2 kinase-
catalyzed phosphorylation and thus to promote protein syn-
thesis in the presence of active eIF-2 kinases.
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FIG. 5. eIf-2 a-subunit phosphorylation lysate
KRC-7 cells grown under various conditions.,ug of protein in lysates from confluent (lanes -72 serum-starved
(lanes -64 hr through 0 hr), and PMA-induced
4 hr) KRC-7 cells was used and phosphorylation
eIF-2 a subunit by endogenous eIF-2 kinases
described in Fig. 1. (B) The cell lysates were
polyclonal antibodies. (C) The lysates were preincubated
and were then phosphorylated.
Two widely studied eIF-2 kinases are HRI and dsI. In
heme-deficient reticulocyte lysates, only HRI is active, as dsI
requires double-stranded RNA and ATP for activation. In
this report, we have provided evidence that, in both heme-
supplemented and heme-deficient lysates, HRI is present in
active form and possibly in equal amounts. In heme-
supplemented lysate, this HRI activity is not evident due to
the presence of p67, whereas in heme-deficient lysates p67
appears to be degraded, thus allowing HRI to actively
phosphorylate eIF-2 a subunit. Removal of p67 from both
heme-supplemented and heme-deficient reticulocyte lysates
with p67 antibodies resulted in similar extents of eIF-2 a-sub-
unit phosphorylation. This indicates that the eIF-2 kinase in
active form may be present at the same level in both systems.
These results suggest that eIF-2 a-subunit phosphorylation,
observed in heme-deficient reticulocyte lysate, is not due to
activation of HRI, as is widely believed, but rather to
degradation of p67. We also provide evidence that p67 degra-
dation involves partial deglycosylation in heme-deficient
lysates. It may, therefore, be assumed that hemin, present in
heme-supplemented lysates, prevents p67 deglycosylation,
possibly by inhibiting the deglycosylating enzyme(s).
Reticulocyte lysates also contain another eIF-2 kinase, dsI,
in inactive form, and this eIF-2 kinase is activated in the
presence of double-stranded RNA and ATP (1, 2). Activated
dsI inhibits protein synthesis even in the presence of hemin
and presumably in the presenceof p67. The mechanism of
eIF-2 a-subunit phosphorylation by dsI in the presence of p67
is not clear. Further work will be necessary to examine p67
activity during dsI inhibition of protein synthesis in heme-
supplemented reticulocyte lysate. It may be possible, how-
ever, that dsI is formed in relatively large excess in the
presence of double-stranded RNA and ATP and at a very high
concentration can phosphorylate the eIF-2 a subunit even in
the presence of equimolar concentrations ofp67.
Like heme-supplemented reticulocyte lysates, the cell ly-
sates prepared from rat brain, rat liver, and confluent and
PMA-induced tumor hepatoma cells (KRC-7) contain both
p67 andeIF-2 kinase(s)in active forms, and eIF-2 kinase
activity becomes evident only after removal ofp67 with p67
antibodies. However, these eIF-2 kinases have not been
characterized. The amount of dsI polypeptide is essentially
unchanged in tumor hepatoma cells under various growth
conditions. This includes confluency, serum starvation, and
mitogen stimulation (Fig. 4). Again, it is not clear whether
thisdsI is in an active form. Our results show that these cells
contain at least one eIF-2 kinase in an active form; however,
this eIF-2 kinase has not been identified as yet as dsl. As
noted,dsI exists in an inactive form in the cells and requires
double-stranded RNA and ATP for activation. The cell
extracts used in this study were not treated with double-
stranded RNA and ATP. Also, our present work suggests
that the HRI may be a normal cell constituent, as this
inhibitor is present in an active form and in approximately
equal amounts in both heme-supplemented and heme-
deficient reticulocyte lysates. Possibly a HRI-like eIF-2
kinase is present in an active form in all animal cells anddsl
activation serves specialized functions under certain physi-
ological conditions. As postulated earlier, this inhibitor (dsl)
may be formed in large excess upon activation under certain
physiological conditions, such as virus infections, and may
inhibit protein synthesis in the presence of normal p67 con-
centrations.
The roles and requirements for p67 in KRC-7 cells under
various growth conditions are clearly evident. This polypep-
tide is present in high concentrations in confluent cells and
disappears rapidly from the cells after serum depletion with
an accompanying decrease in the protein synthesis rate in the
cells. Also, this polypeptide reappears soon after PMA
addition to the serum-starved resting cells as the cells regain
542 Biochemistry: Ray et al.
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protein synthesis activity. Thus, there is a clear correlation
between the p67 level and the protein synthesis activity of the
cells, indicating a direct involvement of p67 in protein syn-
thesis. Furthermore, a comparison of the p67 levels studied
using monoclonal (Fig. 4, row a) and polyclonal (Fig. 4, row
b) antibodies reveals (in agreement with our previous obser-
vation with the heme-deficient reticulocyte lysates, Fig. 3)
that the initial event in p67 degradation involves deglycosy-
lation of p67 and deglycosylated p67 is unstable and is subse-
quently degraded. These results, therefore, establish the
following facts. (i) p67 is necessary to protect the eIF-2 a
subunit from eIF-2 kinase-catalyzed phosphorylation and
thus to promote protein synthesis in the presence of active
eIF-2 kinase(s). (ii) At least one eIF-2 kinase is present in all
of the cells in active form under various growth conditions.
(iii) p67 is degraded rapidly in serum-depleted cells thus
allowing eIF-2 kinase(s) to phosphorylate eIF-2 and inhibit
protein synthesis. (iv) The initial event of p7 degradation
involves deglycosylation of the p67 polypeptide.
An important aspect of p67 regulation is that this is the only
polypeptide presently studied that is both easily degradable
and inducible. The levels of this polypeptide correlate directly
to the protein synthesis activities ofthe cells. As evident in this
study, the initial event for degradation involves deglycosyla-
tion of p67. The deglycosylated p67 is unstable and subse-
quently degraded. Again, addition ofa mitogen, such as PMA,
induces increased appearance of p67, presumably by transcrip-
tion activation of the p67 gene. Thus, p67 level in the cell is
regulated both transcriptionally and posttranscriptionally.
This factor is essential for protein synthesis and thus plays a
critical role in protein synthesis regulation.
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